FAKTOR OPTIONSSCHEIN - EVOTEC Share Price

Certificat

DE000HD525E7

Real-time BOERSE MUENCHEN 03:15:03 03/06/2024 pm IST
3.73 EUR +5.37% Intraday chart for FAKTOR OPTIONSSCHEIN - EVOTEC
1 month-77.85%
Date Price Change
03/24/03 3.73 +5.37%
31/24/31 3.54 +16.83%
30/24/30 3.03 -9.01%
29/24/29 3.33 -40.64%
28/24/28 5.61 -13.82%

Real-time BOERSE MUENCHEN

Last update June 03, 2024 at 03:15 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying EVOTEC SE
IssuerLogo Issuer UniCredit UniCredit
WKN HD525E
ISINDE000HD525E7
Date issued 26/04/2024
Strike 7.578
Maturity Unlimited
Parity 0.33 : 1
Emission price 12.54
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 26.79
Lowest since issue 2.8
Spread 0.04
Spread %1.08%

Company Profile

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Sector
-
More about the company

Ratings for Evotec SE

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Evotec SE

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
8.655 EUR
Average target price
20.79 EUR
Spread / Average Target
+140.21%
Consensus